Business Wire

KORE and Able Device Announce Agreement to Deploy Enterprise Customer Pilots for SIMbae™

Del

KORE, the people powering the Internet-of-Things (IoT) innovations and opportunities, and Able Device, a pioneer in SIM-based IoT and M2M application technology, today announced an agreement to deploy enterprise customer pilots that embed Able Device’s flagship offering, SIMbae, on KORE IoT SIMs (Subscriber Identity Modules). SIMbae, a new and innovative SIM-based solution utilizes established 3GPP standards and provides valuable tools on KORE SIMs to solve common IoT device deployment issues related to network connectivity, commercial and service requirements, and data roaming.

“Large scale deployments of IoT services, particularly global services, must be driven with greater ease and reliability of roll out,” said Alex Brisbourne, KORE CEO. “The goal is to move as close as possible to plug and play deliveries as well as simplified, automated, service connectivity around the globe. A perfect complement to our subscription management/eSIM solutions which already have over 1.2m connections depending upon it, integrating SIMBae provides a further level of automated service assurance,” concluded Brisbourne.

With deployments beginning in March 2017, customer pilots will initially center around three IoT use cases:

  • The first case focuses on troubleshooting an IoT device that is not reporting into the server. In this scenario, SIMbae reports mobile-specific network information such as signal strength, neighboring cells, and other key metrics to determine the connectivity issue.
  • A second case addresses an IoT device roaming onto a network that doesn’t meet commercial or service requirements and is then resolved through implementing SIMbae’s Dynamic PLMN Manager.
  • The third scenario deployed during the pilots will utilize SIMbae’s Packet Data Reporter to change networks when a device roams onto a network that doesn’t support data roaming. Additionally, by embedding these tools on KORE’s SIMs and utilizing 3GPP standards, a consistent high level of application and communications security is achieved.

“We’re extremely excited to enter into real world, enterprise commercial pilots with KORE as they were the first service provider we approached when SIMbae was conceived,” stated Roger Dewey, CEO and Founder of Able Device. “The reason for this was KORE’s strong vision and early leadership in offering the enterprise market high value services to deploy IoT projects in a very flexible model.” He continued by saying, “Able Device and KORE share a philosophy centered on ease of development, deployment, security, and operation for mobile IoT applications. The standard SIM is the perfect vehicle for realizing that vision on a mass scale, but the SIM is not enough as it needs to be coupled with enterprise centric services.”

To visit with KORE during Mobile World Congress 2017 to learn more about these new and innovative SIM-based tools and how can they can simplify and secure your IoT deployments, contact Jacqueline Tait at jtait@korewireless.com.

About KORE

KORE provides the connectivity and services that make the Internet of Things possible. Founded in 2003, KORE is the world’s largest managed network services provider specializing in Internet of Things (IoT) and Machine to Machine (M2M) markets. KORE provides the critical wireless IoT connectivity empowering application, hardware and wireless operator partners to rapidly bring new IoT and M2M innovations to market, with millions of active on-network units in more than 180 countries. KORE delivers choice, reliability and global native coverage through multi-carrier and Tier 1 carrier cellular and satellite network services – including LTE, GSM and CDMA - as well as advanced applications to easily manage IoT connected devices. KORE Position Logic software provides seamless location-based services (LBS) for businesses. KORE’s recent acquisition of Wyless makes the company one of the six largest providers of M2M/IoT services globally, inclusive of carriers.

For more information, visit www.koretelematics.com, read the KORE blog and connect with KORE on LinkedIn, Google+, Facebook, Twitter, YouTube and Vimeo.

About Able Device

Able Device is a provider of technology for Mobile Network Operators (MNOs) and IoT service providers. Its flagship product SIMbae™ (short for "SIM based application engine") enables hosting of IoT device controls and applications on standard SIMs. In this new architecture, the SIM is transformed to an intelligent independent processor. As SIMbae utilizes established and common 3GPP SIM standards, IoT controls and applications implemented this way become device and carrier agnostic - with benefits including shorter time to market, reduced development cost, lower operating cost, and improved security. Based in Raleigh, NC, Able Device serves mobile network operators globally.

For more information, visit www.abledevice.com.

All products/services and trademarks mentioned in this release are the properties of their respective companies.

Contact information

For KORE
MSLGROUP Boston
Joe Palladino or Maggie Fairchild
+1 781-684-0770
kore@mslgroup.com
or
For Able Device
Leigh Ann Ryals, +1 919-809-6822
info@abledevice.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

NEORIS Announces Creation of Innovation Labs Worldwide to Create a Smarter Future19.7.2018 15:32Pressemelding

NEORIS, a global digital consulting services company, announced today it is consolidating the most innovative solutions it has developed in different geographies and allocating unprecedented resources to deploy a network of Innovation Labs worldwide. The main objective is to lay the foundation for the continuous development of disruptive solutions for its four core industries: Manufacturing, Financial Services, Healthcare and Telecommunications. Due to its disruptive nature, NEORIS decided that its first Innovation Lab should be housed in the Monterrey Digital Hub, which today is the first-of-its-kind as it is a space where entrepreneurs, companies, universities and investors converge to foster an ecosystem for Digital Transformation. The lab inaugurated in Monterrey, Mexico is the first of a series of Innovation Labs that will open in the different countries that NEORIS operates, and is a space where customers can experience emerging technologies through real-life scenarios. One such

CORRECTING and REPLACING Albar Capital Deploys FlexNOW19.7.2018 15:29Pressemelding

Subhead of release should read: Out-of-the-Box Multi-Asset Execution Management System (instead of Easy-to-Install Multi-Asset Execution Management System). The corrected release reads: ALBAR CAPITAL DEPLOYS FLEXNOW Out-of-the-Box Multi-Asset Execution Management System FlexTrade (@FlexTrade) today announced that Albar Capital Ltd., a new hedge fund led by Javier Velazquez (formerly of Millennium Capital Partners LLP), is now trading equities and futures using FlexNOW, FlexTrade’s new execution management system. “The FlexNOW team was instrumental in solving several of our problems,” said Jason Ruder, Trader at Albar Capital. “Not only are they helping us with our compliance requirements, they are also responsive to requests that improve my workflow.” According to Rhyd Lewis, FlexNOW Product Manager, FlexNOW’s quick onboarding and easy installation process was critical for Albar Capital’s launch on 2 July. “We had no problem integrating FlexNOW with Albar’s portfolio and risk managemen

Full Core of Westinghouse Fuel Achieved at South-Ukraine Nuclear Power Plant Unit 319.7.2018 13:25Pressemelding

Westinghouse Electric Company announced today that Ukraine’s State Enterprise National Nuclear Energy Generation Company (SE NNEGC) Energoatom’s South-Ukraine NPP Unit 3 near Yuzhnoukrainsk in Mykolaiv province was loaded with a full core of Westinghouse VVER-1000 fuel. This is the first unit in Ukraine to operate with Westinghouse VVER-1000 fuel assemblies as the sole fuel source. “Westinghouse began supplying fuel to Ukraine in 2005, when the first lead test assemblies were delivered to South-Ukraine Unit 3,” said Aziz Dag, vice president and managing director, Northern Europe. “We are proud to continue supporting Ukraine with their energy diversification by supplying a full core of Westinghouse VVER-1000 fuel to our customer, Energoatom.” Westinghouse currently supplies fuel to six of Ukraine’s 15 nuclear power reactors. Beginning in 2021, the number of reactors with Westinghouse fuel will increase to seven. “Westinghouse has made significant investments over the last several years

Seoul Semiconductor Delivers Its Innovative LED "SunLike" to U.S. Lighting Market19.7.2018 13:00Pressemelding

Seoul Semiconductor Co., Ltd. (KOSDAQ:046890), a market leader in LED (light emitting diode) design and manufacturing, announced that its innovative LED “SunLike” is applied to brand new lightings to be launched by three lighting premium brands in U.S., Pure Edge Lighting, LEDRAbrands, Inc. and Elite Lighting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180719005377/en/ The product of LEDRAbrands, Inc., NU4RA-SUN, which applied SunLike of Seoul Semiconductor (Photo: Business Wire) Seoul Semiconductor supplies SunLike to pendant lighting for Pure Edge, a U.S. lighting solution company. It is applied to high-end lighting for museums and art galleries that require the highest color quality. The leading lighting design companies, LEDRAbrands, Inc. and Elite Lighting, apply SunLike to downlights and spotlights respectively. “We have selected Seoul Semiconductor’s innovative LED SunLike for our human centric lighting and believ

Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors19.7.2018 12:30Pressemelding

Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors (TCRs), have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers. Under the financial terms, Kite will provide research and development (R&D) funding for the collaboration and Gadeta will be eligible to receive future payments upon achievement of certain regulatory milestones. In addition, Kite will make an upfront purchase of equity in Gadeta from Gadeta’s shareholders and may acquire additional equity in Gadeta upon achievement of certain R&D milestones. Kite will have the exclusive option to acquire Gadeta. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180719005418/en/ Gadeta has developed a proprietary technology to engineer alpha beta T cells with gamma delta TCRs, called TEGs, for

Boehringer Ingelheim and Lilly announce Trajenta®’s CARMELINA® cardiovascular outcome trial met its primary endpoint19.7.2018 12:08Pressemelding

CARMELINA®1 (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk) met its primary endpoint, defined as time to first occurrence of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke (3-point MACE), with Trajenta® (linagliptin) demonstrating similar cardiovascular safety compared to placebo. Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today positive top-line results, which evaluated the impact of treatment with linagliptin vs. placebo on cardiovascular safety on top of standard of care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180719005409/en/ The study included 6,979 adults with type 2 diabetes and high cardiovascular risk.1 The majority of patients also had kidney disease, an important risk factor for cardiovascular disease. The overall safety profile of linagliptin in CARMELINA®, including adults